Case report: Personalized management of treatment resistance in advanced NSCLC patients with mutated epidermal growth factor receptor: special examples and literature review
The treatment landscape of non-small cell lung cancer (NSCLC) has shifted significantly from empirical, histology-driven, and clinician-directed cytotoxic regimens to a stratified approach predicated on molecular profiling of tumor genetics and immune biomarkers, by the former can indicate targeted...
Saved in:
Main Authors: | Jun Wang, Xiaojing Li, Shuang Dong, Sheng Hu, Fengming Ran, Yu Qian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1525881/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dramatic response of advanced pulmonary sarcomatoid carcinoma to tislelizumab combined with anlotinib: a case report
by: Ranran Li, et al.
Published: (2025-02-01) -
Anti-inflammatory coupled anti-angiogenic airway stent effectively suppresses tracheal in-stents restenosis
by: Yanan Zhao, et al.
Published: (2025-01-01) -
Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada
by: Lara Chayab, et al.
Published: (2024-12-01) -
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
by: Laura Moliner, MD, et al.
Published: (2025-01-01) -
CMSP exerts anti-tumor effects on small cell lung cancer cells by inducing mitochondrial dysfunction and ferroptosis
by: Yan Xi, et al.
Published: (2025-01-01)